The potential role of Akt phosphorylation in human cancers - PubMed (original) (raw)
Review
. 2008 Jan-Mar;23(1):1-9.
doi: 10.1177/172460080802300101.
Affiliations
- PMID: 18409144
- DOI: 10.1177/172460080802300101
Free article
Review
The potential role of Akt phosphorylation in human cancers
J Cicenas. Int J Biol Markers. 2008 Jan-Mar.
Free article
Abstract
Akt/protein kinase B (PKB) is a serine/threonine kinase which is implicated in mediating a variety of biological responses including cell growth, proliferation and survival. Akt is activated by phosphorylation on two critical residues, namely threonine 308 (Thr308) and serine 473 (Ser473). Several studies have found Akt2 to be amplified or overexpressed at the mRNA level in various tumor cell lines and in a number of human malignancies such as colon, pancreatic and breast cancers. Nevertheless, activation of Akt isoforms by phosphorylation appears to be more clinically significant than Akt2 amplification or overexpression. Many studies in the past 4-5 years have revealed a prognostic and/or predictive role of Akt phosphorylation in breast, prostate and non-small cell lung cancer. Several publications suggest a role of phosphorylated Akt also in endometrial, pancreatic, gastric, tongue and renal cancer. However, different types of assays were used in these studies. Before assessment of P-Akt can be incorporated into routine clinical practice, all aspects of the assay methodology will have to be standardized.
Similar articles
- Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer.
Vincent EE, Elder DJ, Thomas EC, Phillips L, Morgan C, Pawade J, Sohail M, May MT, Hetzel MR, Tavaré JM. Vincent EE, et al. Br J Cancer. 2011 May 24;104(11):1755-61. doi: 10.1038/bjc.2011.132. Epub 2011 Apr 19. Br J Cancer. 2011. PMID: 21505451 Free PMC article. - Regulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cells.
Chua BT, Gallego-Ortega D, Ramirez de Molina A, Ullrich A, Lacal JC, Downward J. Chua BT, et al. Mol Cancer. 2009 Dec 31;8:131. doi: 10.1186/1476-4598-8-131. Mol Cancer. 2009. PMID: 20042122 Free PMC article. - Autocrine signalling through erbB receptors promotes constitutive activation of protein kinase B/Akt in breast cancer cell lines.
Nicholson KM, Streuli CH, Anderson NG. Nicholson KM, et al. Breast Cancer Res Treat. 2003 Sep;81(2):117-28. doi: 10.1023/A:1025765215765. Breast Cancer Res Treat. 2003. PMID: 14572154 - Roles of protein kinase B/Akt in lung cancer.
Xu CX, Jin H, Shin JY, Kim JE, Cho MH. Xu CX, et al. Front Biosci (Elite Ed). 2010 Jun 1;2(4):1472-84. doi: 10.2741/e206. Front Biosci (Elite Ed). 2010. PMID: 20515818 Review. - The protein kinase B/Akt signalling pathway in human malignancy.
Nicholson KM, Anderson NG. Nicholson KM, et al. Cell Signal. 2002 May;14(5):381-95. doi: 10.1016/s0898-6568(01)00271-6. Cell Signal. 2002. PMID: 11882383 Review.
Cited by
- Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells.
Martino JJ, Wall BA, Mastrantoni E, Wilimczyk BJ, La Cava SN, Degenhardt K, White E, Chen S. Martino JJ, et al. Oncogene. 2013 Sep 12;32(37):4366-76. doi: 10.1038/onc.2012.471. Epub 2012 Oct 22. Oncogene. 2013. PMID: 23085756 Free PMC article. - Therapeutic value of steroidal alkaloids in cancer: Current trends and future perspectives.
Dey P, Kundu A, Chakraborty HJ, Kar B, Choi WS, Lee BM, Bhakta T, Atanasov AG, Kim HS. Dey P, et al. Int J Cancer. 2019 Oct 1;145(7):1731-1744. doi: 10.1002/ijc.31965. Epub 2019 Jan 21. Int J Cancer. 2019. PMID: 30387881 Free PMC article. Review. - Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation.
Improta G, Zupa A, Fillmore H, Deng J, Aieta M, Musto P, Liotta LA, Broaddus W, Petricoin EF 3rd, Wulfkuhle JD. Improta G, et al. J Proteome Res. 2011 Jul 1;10(7):3089-97. doi: 10.1021/pr200065t. Epub 2011 May 27. J Proteome Res. 2011. PMID: 21574647 Free PMC article. - The Aurora kinase inhibitors in cancer research and therapy.
Cicenas J. Cicenas J. J Cancer Res Clin Oncol. 2016 Sep;142(9):1995-2012. doi: 10.1007/s00432-016-2136-1. Epub 2016 Mar 1. J Cancer Res Clin Oncol. 2016. PMID: 26932147 Review. - Rosemary Extract Inhibits Proliferation, Survival, Akt, and mTOR Signaling in Triple-Negative Breast Cancer Cells.
Jaglanian A, Tsiani E. Jaglanian A, et al. Int J Mol Sci. 2020 Jan 27;21(3):810. doi: 10.3390/ijms21030810. Int J Mol Sci. 2020. PMID: 32012648 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous